Naturally Selected

By Sarah Greene Naturally Selected Ninety thousand ways to make you smarter. Can the molecular biologist afford to ignore developments in systems biology, bioinformatics, structural biology, and now even physics? Many thanks to readers who responded to my inaugural editorial (in the February issue), calling for feedback on the “next new thing.” To some, the thing was the t-shirt (we’re working on that), othe

Written bySarah Greene
| 3 min read

Register for free to listen to this article
Listen with Speechify
0:00
3:00
Share

Many thanks to readers who responded to my inaugural editorial (in the February issue), calling for feedback on the “next new thing.” To some, the thing was the t-shirt (we’re working on that), others wanted hats, while the more persnickety called for a total revamp of scientific research, publishing, and reporting. Here ideas ran the gamut from ditching peer review, to mandating interdisciplinary-infused research, to less US-centricity, to investigative myth-busting, to crowd-sourced experimental design, to a “Journal of Fantastic Failures.” And there resonated a need for context and depth. Instead of, or in addition to, pouncing on what’s new and now, you said papers should be examined retrospectively—after weeks, months, and even years to reveal which hypotheses and experiments have shone light upon the dark and vast terrain of the unknown.

Every generation of scientists must keep the enlightenment flame alive, and much has been written about whether those weaned ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here

Meet the Author

Published In

Share
Image of a man in a laboratory looking frustrated with his failed experiment.
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies